To our knowledge, there is no report on the changes to SNAP29 after stroke and its associated significance, so our study suggests a novel therapeutic target against cognitive impairment following cerebral ischemia via maintaining the function of SNAP29. The gene discussed is SNAP29; the disease is Cognitive impairment.